Literature DB >> 8528578

Discrimination by the NO-trapping agent, carboxy-PTIO, between NO and the nitrergic transmitter but not between NO and EDRF.

M J Rand1, C G Li.   

Abstract

1. The effects of carboxy-PTIO, a scavenger of free radical nitric oxide (NO), were studied on endothelium-dependent relaxations of rat aorta and nitrergic nerve stimulation-induced relaxations of anococcygeus muscle and gastric fundus strips to test the hypothesis that endothelium-derived relaxing factor (EDRF) and the transmitter released by nitrergic nerves is free radical NO. 2. Carboxy-PTIO (10-300 microM) produced concentration-dependent reductions of relaxations elicited by exogenous NO, and relaxations mediated by EDRF released by acetylcholine and ATP in rings of rat aorta. The inhibitory effect of carboxy-PTIO was removed by washing the tissues. 3. In the rat anococcygeus muscle, carboxy-PTIO (10-300 microM) produced concentration-dependent reductions of relaxations to exogenous NO; however, in concentrations up to 2000 microM it did not reduce relaxations elicited by nitrergic nerve stimulation (1-2 Hz), in fact, concentrations of 300 microM or more slightly enhanced them. 4. In rat gastric fundus strips, carboxy-PTIO (100 and 300 microM) reduced relaxations to exogenous NO, but relaxations elicited by stimulation of the nitrergic component of non-adrenergic, non-cholinergic nerves were not affected. 5. These results suggest that EDRF is free radical NO and may be designated EDNO, but the transmitter released from nitrergic nerves does not appear to be identical to EDNO and may not be free radical NO.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8528578      PMCID: PMC1909095          DOI: 10.1111/j.1476-5381.1995.tb16681.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

Review 1.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

2.  Differentiation by hydroquinone of relaxations induced by exogenous and endogenous nitrates in non-vascular smooth muscle: role of superoxide anions.

Authors:  A J Hobbs; J F Tucker; A Gibson
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

3.  Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide.

Authors:  P R Myers; R L Minor; R Guerra; J N Bates; D G Harrison
Journal:  Nature       Date:  1990-05-10       Impact factor: 49.962

4.  The effects of pyrogallol and hydroquinone on the response to NANC nerve stimulation in the rat anococcygeus and the bovine retractor penis muscles.

Authors:  J S Gillespie; H Sheng
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

5.  Evidence for a role of nitric oxide in the neurotransmitter system mediating relaxation of the rat anococcygeus muscle.

Authors:  C G Li; M J Rand
Journal:  Clin Exp Pharmacol Physiol       Date:  1989-12       Impact factor: 2.557

6.  NANC neurotransmission in the bovine retractor penis muscle is blocked by superoxide anion following inhibition of superoxide dismutase with diethyldithiocarbamate.

Authors:  W Martin; K H McAllister; K Paisley
Journal:  Neuropharmacology       Date:  1994-11       Impact factor: 5.250

7.  Effects of NG-substituted analogues of L-arginine on NANC relaxation of the rat anococcygeus and bovine retractor penis muscles and the bovine penile artery.

Authors:  X R Liu; J S Gillespie; I F Gibson; W Martin
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

8.  EDRF: nitrosylated compound or authentic nitric oxide.

Authors:  J N Bates; D G Harrison; P R Myers; R L Minor
Journal:  Basic Res Cardiol       Date:  1991       Impact factor: 17.165

9.  The rat anococcygeus muscle and its response to nerve stimulation and to some drugs.

Authors:  J S Gillespie
Journal:  Br J Pharmacol       Date:  1972-07       Impact factor: 8.739

10.  Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus.

Authors:  C G Li; M J Rand
Journal:  Eur J Pharmacol       Date:  1990-12-04       Impact factor: 4.432

View more
  19 in total

1.  Comparison of the redox forms of nitrogen monoxide with the nitrergic transmitter in the rat anococcygeus muscle.

Authors:  C G Li; J Karagiannis; M J Rand
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

Review 2.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

3.  Comparison of the effects of hydroxocobalamin and oxyhaemoglobin on responses to NO, EDRF and the nitrergic transmitter.

Authors:  M La; C G Li; M J Rand
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  Effect of Cu2+ on relaxations to the nitrergic neurotransmitter, NO and S-nitrosothiols in the rat gastric fundus.

Authors:  J G De Man; B Y De Winter; G E Boeckxstaens; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

5.  Effect of thiol modulators and Cu/Zn superoxide dismutase inhibition on nitrergic relaxations in the rat gastric fundus.

Authors:  J G De Man; B Y De Winter; G E Boeckxstaens; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

6.  Antioxidant protection of NO-induced relaxations of the mouse anococcygeus against inhibition by superoxide anions, hydroquinone and carboxy-PTIO.

Authors:  E Lilley; A Gibson
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

7.  Effects of hydroxocobalamin and carboxy-PTIO on nitrergic transmission in porcine anococcygeus and retractor penis muscles.

Authors:  C G Li; M J Rand
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

8.  Differential cardiovascular responses to blockade of nNOS or iNOS in rostral ventrolateral medulla of the rat.

Authors:  S H Chan; L L Wang; S H Wang; J Y Chan
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

9.  Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes.

Authors:  J W Wegener; E I Closs; U Förstermann; H Nawrath
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

Review 10.  iNOS: a potential therapeutic target for malignant glioma.

Authors:  A Jahani-Asl; A Bonni
Journal:  Curr Mol Med       Date:  2013-09       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.